Metronomic oral cyclosphosphamide as third-line systemic treatment or beyond in patients with inoperable locoregionally advanced recurrent or metastatic nasopharyngeal carcinoma

There is no standard third-line or further systemic treatment for patients with inoperable locoregionally advanced recurrent or metastatic nasopharyngeal carcinoma (NPC). Metronomic oral cyclophosphamide provides an acceptable and cheap option for these heavily pretreated patients who had limited ch...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Medicine (Baltimore)
Main Authors: Lee, Victor H.F., Kwong, Dora L.W., Lam, Ka-On, Lai, Yu-Ching, Li, Yun, Tong, Chi-Chung, Ho, Patty P.Y., Chan, Wing-Lok, Wong, Lai-San, Leung, Dennis K.C., Chan, Sum-Yin, Chan, Fong-Ting, Leung, To-Wai, Lee, Anne W.M.
Formato: Artigo
Idioma:Inglês
Publicado em: Wolters Kluwer Health 2017
Assuntos:
5700
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5403079/
https://ncbi.nlm.nih.gov/pubmed/28403082
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MD.0000000000006518
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados